why choose us

First received: August 18, 2023

Clinical Trial: Efficacy and Safety of Adjunctive Minocycline in the Treatment of Autoimmune Encephalitis

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Autoimmune Encephalitis

Study Type: INTERVENTIONAL


Official Title: Efficacy and Safety of Adjunctive Minocycline in the Treatment of Autoimmune Encephalitis: Open-lable, Randomised, Proof of Concept Study

Brief Summary: Autoimmune encephalitis (AE) is an immune-mediated brain disorder characterized by varied clinical manifestations that correlate with specific types of antibodies.Typical symptoms include acute behavioral changes, psychosis, seizures, memory deficits, dyskinesias, speech impairments, and autonomic and respiratory dysregulation.While the majority of patients respond well to immunotherapeutic agents, a significant proportion remains resistant to initial and secondary-line immunotherapies.Minocycline, a semisynthetic…

Read more